- Home
- GTBP vs BKYI Comparison
GTBP vs BKYI Comparison
Compare GTBP & BKYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- BKYI
- Stock Information
- Founded
- GTBP 1965
- BKYI 1993
- Country
- GTBP United States
- BKYI United States
- Employees
- GTBP N/A
- BKYI N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- BKYI Computer Software: Prepackaged Software
- Sector
- GTBP Health Care
- BKYI Technology
- Exchange
- GTBP Nasdaq
- BKYI Nasdaq
- Market Cap
- GTBP 5.5M
- BKYI 4.8M
- IPO Year
- GTBP N/A
- BKYI 1997
- Fundamental
- Price
- GTBP $0.95
- BKYI $0.75
- Analyst Decision
- GTBP Strong Buy
- BKYI
- Analyst Count
- GTBP 1
- BKYI 0
- Target Price
- GTBP $11.00
- BKYI N/A
- AVG Volume (30 Days)
- GTBP 292.5K
- BKYI 127.4K
- Earning Date
- GTBP 08-14-2025
- BKYI 08-13-2025
- Dividend Yield
- GTBP N/A
- BKYI N/A
- EPS Growth
- GTBP N/A
- BKYI N/A
- EPS
- GTBP N/A
- BKYI N/A
- Revenue
- GTBP N/A
- BKYI $6,911,148.00
- Revenue This Year
- GTBP N/A
- BKYI $7.45
- Revenue Next Year
- GTBP N/A
- BKYI $23.29
- P/E Ratio
- GTBP N/A
- BKYI N/A
- Revenue Growth
- GTBP N/A
- BKYI N/A
- 52 Week Low
- GTBP $0.88
- BKYI $0.52
- 52 Week High
- GTBP $4.10
- BKYI $3.68
- Technical
- Relative Strength Index (RSI)
- GTBP 26.68
- BKYI 45.80
- Support Level
- GTBP $0.88
- BKYI $0.71
- Resistance Level
- GTBP $0.99
- BKYI $0.77
- Average True Range (ATR)
- GTBP 0.10
- BKYI 0.04
- MACD
- GTBP 0.01
- BKYI 0.00
- Stochastic Oscillator
- GTBP 9.92
- BKYI 32.46
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.